Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc. - Florida, has received approval from the US Food and Drug Administration (FDA) for its ...
Acadia Pharmaceuticals of San Diego and its Canadian partner Biovail are continuing to move ahead with pimavanserin. The experimental drug, you might recall, failed last September in a trial ...
NEW YORK (MarketWatch) -- Biovail Corp. (NYSE:BVF) said its fourth-quarter net income fell to $73 million, or 46 cents a share, from $120.4 million, or 76 cents a share, in the year-ago period ...
Biovail Declares Quarterly Dividend - Business Wire
Biovail Reports Fourth Quarter, Year-End 2009 Financial Results - Trading Markets
News-Medical.net
- Benzinga
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Mark K. Oki has been promoted to Vice President, Finance and Controller. Mr. Oki joined Alexza as Controller and Director in 2006 ...
AP , 02.22.10, 10:52 AM EST CORONA, Calif. -- Watson Pharmaceuticals said Monday that it is being sued by Biovail Corp. after it sought federal approval for a generic version of that company's ...
Watson Files FDA Application for Generic Aplenzin(TM) ER - Trading Markets
Watson Pharma (WPI) Subsidiary Files ANDA with US FDA for Bupropion Hydrobromide Tablets (BVF) - StreetInsider.com
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE/TSX: BVF) today acknowledged that separate Complaints have been filed against the Company by SAC Capital Advisors, LLC and Gradient Analytics ...
Mountain, CA.,/PRNewswire via COMTEX/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the US Food & Drug Administration has accepted the AZ-004 NDA for filing and has indicated ...
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that it will host a conference call and Webcast on Thursday, February 25, 2010, at 8:30 am EST, for Company ...
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) increased 10.47% to $2.95 in the pre-market session. Alexza Pharmaceuticals announced today that it has established a collaboration with Biovail ...
MOUNTAIN VIEW, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has established a collaboration with Biovail Laboratories International ...
Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004 - Business Wire
Alexza, Biovail to commercialize psychiatric drug - MarketWatch
StreetInsider.com
- News-Medical.net
- PharmaLive.com
For full details on Biovail Corp (BVF) BVF. Biovail Corp (BVF) has Short Term PowerRatings at TradingMarkets. Details on Biovail Corp (BVF) Short Term PowerRatings is available at This Link. Learn ...
Biovail (BVF), the drugmaker, slammed rival Teva (TEVA), saying a proposed clinical trial of a generic version of Biovail's Wellbutrin XL antidepressant is too small and brief to be useful.
TORONTO - (Business Wire) Biovail Corporation (NYSE/TSX: BVF) today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is ...
USA 
